|
|
|
|
| LEADER |
01000naa a22002652 4500 |
| 001 |
NLM301193886 |
| 003 |
DE-627 |
| 005 |
20231225104123.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
231225s2019 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1021/acs.langmuir.9b02300
|2 doi
|
| 028 |
5 |
2 |
|a pubmed24n1003.xml
|
| 035 |
|
|
|a (DE-627)NLM301193886
|
| 035 |
|
|
|a (NLM)31510746
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Wu, Fan
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Hyaluronic Acid-Modified Porous Carbon-Coated Fe3O4 Nanoparticles for Magnetic Resonance Imaging-Guided Photothermal/Chemotherapy of Tumors
|
| 264 |
|
1 |
|c 2019
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 21.09.2020
|
| 500 |
|
|
|a Date Revised 21.09.2020
|
| 500 |
|
|
|a published: Print-Electronic
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a Chemotherapy is an effective method for treating cancer, clinically. However, side effects of drug and multidrug resistance restrict its application. In recent years, the combined treatment of chemotherapy and photothermal therapy (PTT) is becoming a promising method for treating cancer. PTT utilizes nanomaterials absorbing near-infrared light and producing heat to acquire advanced hyperthermia strategy for cancer treatment. Carbon nanomaterials with good biocompatibility, high surface area, and excellent photothermal properties are an excellent nanoplatform for drug delivery and PTT. Herein, porous carbon-coated magnetite nanoparticles (PCCMNs) were successfully synthesized by a one-pot solvothermal method. Magnetite, a contrast agent, can be used for magnetic resonance imaging. Hyaluronic acid was used to modify the PCCMNs to achieve targeted therapy. The obtained nanohybrid with a good photothermal effect can realize combined PTT/chemotherapy and will be a promising nanoplatform for high efficacy theranostics
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
| 650 |
|
7 |
|a Antineoplastic Agents
|2 NLM
|
| 650 |
|
7 |
|a Contrast Media
|2 NLM
|
| 650 |
|
7 |
|a Drug Carriers
|2 NLM
|
| 650 |
|
7 |
|a Magnetite Nanoparticles
|2 NLM
|
| 650 |
|
7 |
|a Carbon
|2 NLM
|
| 650 |
|
7 |
|a 7440-44-0
|2 NLM
|
| 650 |
|
7 |
|a Doxorubicin
|2 NLM
|
| 650 |
|
7 |
|a 80168379AG
|2 NLM
|
| 650 |
|
7 |
|a Hyaluronic Acid
|2 NLM
|
| 650 |
|
7 |
|a 9004-61-9
|2 NLM
|
| 700 |
1 |
|
|a Sun, Baohong
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Chu, Xiaohong
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Zhang, Qicheng
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a She, Zhangcai
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Song, Saijie
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Zhou, Ninglin
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Zhang, Jun
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Yi, Xinyao
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Wu, Daohong
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Wang, Jianxiu
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Langmuir : the ACS journal of surfaces and colloids
|d 1992
|g 35(2019), 40 vom: 08. Okt., Seite 13135-13144
|w (DE-627)NLM098181009
|x 1520-5827
|7 nnns
|
| 773 |
1 |
8 |
|g volume:35
|g year:2019
|g number:40
|g day:08
|g month:10
|g pages:13135-13144
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1021/acs.langmuir.9b02300
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_22
|
| 912 |
|
|
|a GBV_ILN_350
|
| 912 |
|
|
|a GBV_ILN_721
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 35
|j 2019
|e 40
|b 08
|c 10
|h 13135-13144
|